Three-dimensional study of Alzheimer's disease hallmarks using the iDISCO clearing method

od Liebmann, Thomas, Renier, Nicolas, Bettayeb, Karima, Greengard, Paul, Tessier-Lavigne, Marc, Flajolet, Marc
Wydane w Cell Rep (2016)

Gleevec shifts APP processing from a β-cleavage to a nonamyloidogenic cleavage

od Netzer, William J., Bettayeb, Karima, Sinha, Subhash C., Flajolet, Marc, Greengard, Paul, Bustos, Victor
Wydane w Proc Natl Acad Sci U S A (2017)

Small-molecule inducers of Aβ-42 peptide production share a common mechanism of action

od Bettayeb, Karima, Oumata, Nassima, Zhang, Yuanyuan, Luo, Wenjie, Bustos, Victor, Galons, Hervé, Greengard, Paul, Meijer, Laurent, Flajolet, Marc
Wydane 2012

δ-COP modulates Aβ peptide formation via retrograde trafficking of APP

od Bettayeb, Karima, Chang, Jerry C., Luo, Wenjie, Aryal, Suvekshya, Varotsis, Dante, Randolph, Lisa, Netzer, William J., Greengard, Paul, Flajolet, Marc
Wydane w Proc Natl Acad Sci U S A (2016)

Gamma-secretase activating protein, a therapeutic target for Alzheimer's disease

od He, Gen, Luo, Wenjie, Li, Peng, Remmers, Christine, Netzer, William, Hendrick, Joseph, Bettayeb, Karima, Flajolet, Marc, Gorelick, Fred, Wennogle, Lawrence P., Greengard, Paul
Wydane 2010

Relevance of the COPI complex for Alzheimer’s disease progression in vivo

od Bettayeb, Karima, Hooli, Basaraj V., Parrado, Antonio R., Randolph, Lisa, Varotsis, Dante, Aryal, Suvekshya, Gresack, Jodi, Tanzi, Rudolph E., Greengard, Paul, Flajolet, Marc
Wydane w Proc Natl Acad Sci U S A (2016)

Soluble 3′, 6-substituted indirubins with enhanced selectivity towards glycogen synthase kinase -3 alter circadian period

od VOUGOGIANNOPOULOU, Konstantina, FERANDIN, Yoan, BETTAYEB, Karima, MYRIANTHOPOULOS, Vassilios, LOZACH, Olivier, FAN, Yunzhen, JOHNSON, Carl Hirschie, MAGIATIS, Prokopios, SKALTSOUNIS, Alexios-Leandros, MIKROS, Emmanuel, MEIJER, Laurent
Wydane 2008

Aftins Increase Amyloid-β(42), Lower Amyloid-β(38), and Do Not Alter Amyloid-β(40) Extracellular Production in vitro: Toward a Chemical Model of Alzheimer’s Disease?

od Hochard, Arnaud, Oumata, Nassima, Bettayeb, Karima, Gloulou, Olfa, Fant, Xavier, Durieu, Emilie, Buron, Nelly, Porceddu, Mathieu, Borgne-Sanchez, Annie, Galons, Hervé, Flajolet, Marc, Meijer, Laurent
Wydane w J Alzheimers Dis (2013)

CDK Inhibitors Roscovitine and CR8 Trigger Mcl-1 Down-Regulation and Apoptotic Cell Death in Neuroblastoma Cells

od Bettayeb, Karima, Baunbæk, Dianne, Delehouze, Claire, Loaëc, Nadège, Hole, Alison J., Baumli, Sonja, Endicott, Jane A., Douc-Rasy, Setha, Bénard, Jean, Oumata, Nassima, Galons, Hervé, Meijer, Laurent
Wydane 2010

Pyrazolo[1,5-a]-1,3,5-triazine as a purine bioisostere: access to potent CDK inhibitor (R)-roscovitine analogue

od Popowycz, Florence, Fournet, Guy, Schneider, Cédric, Bettayeb, Karima, Ferandin, Yoan, Lamigeon, Cyrile, Tirado, Oscar M., Mateo-Lozano, Silvia, Notario, Vicente, Colas, Pierre, Bernard, Philippe, Meijer, Laurent, Joseph, Benoît
Wydane 2009

GSAP regulates lipid homeostasis and mitochondrial function associated with Alzheimer’s disease

od Xu, Peng, Chang, Jerry C., Zhou, Xiaopu, Wang, Wei, Bamkole, Michael, Wong, Eitan, Bettayeb, Karima, Jiang, Lu-Lin, Huang, Timothy, Luo, Wenjie, Xu, Huaxi, Nairn, Angus C., Flajolet, Marc, Ip, Nancy Y., Li, Yue-Ming, Greengard, Paul
Wydane w J Exp Med (2021)